Your browser doesn't support javascript.
loading
Endovascular and Surgical Treatment Is Predictive of Readmission Risk After Aneurysmal Subarachnoid Hemorrhage.
Chatrath, Ajay; Soldozy, Sauson; Sokolowski, Jennifer D; Burke, Rebecca M; Schultz, Julianne G; Rannigan, Zuseen C; Park, Min S.
Afiliação
  • Chatrath A; Department of Neurological Surgery, University of Virginia, Charlottesville, Virginia, USA.
  • Soldozy S; Department of Neurological Surgery, University of Virginia, Charlottesville, Virginia, USA.
  • Sokolowski JD; Department of Neurological Surgery, University of Virginia, Charlottesville, Virginia, USA.
  • Burke RM; Department of Neurological Surgery, University of Virginia, Charlottesville, Virginia, USA.
  • Schultz JG; Department of Neurological Surgery, University of Virginia, Charlottesville, Virginia, USA.
  • Rannigan ZC; Department of Neurological Surgery, University of Virginia, Charlottesville, Virginia, USA.
  • Park MS; Department of Neurological Surgery, University of Virginia, Charlottesville, Virginia, USA. Electronic address: MP2TQ@hscmail.mcc.virginia.edu.
World Neurosurg ; 142: e494-e501, 2020 10.
Article em En | MEDLINE | ID: mdl-32693223
BACKGROUND: Aneurysmal subarachnoid hemorrhage (aSAH) is a debilitating disease process accounting for 5% of strokes. Although improvements in care have reduced the case-fatality rates, patients have an increased risk of neurological and medical complications after discharge. Additionally, the readmission rates have been increasingly used as a metric for patient care quality. METHODS: In the present study, we reviewed the medical records of 206 patients who had been treated for aSAH at the University of Virginia from 2011 to 2018 to identify the causes and predictors of readmission. RESULTS: The all-cause readmission rate was 9.8%, 15.3%, and 21.3% within 30, 60, and 180 days, respectively. The readmission rate for neurologic causes was 7.7%, 12.6%, and 18.0% within 30, 60, and 180 days, respectively. The neurologic causes of readmission included aneurysm retreatment, cranioplasty, a fall, hydrocephalus, stroke symptoms, and syncope. Surgical treatment (odds ratio [OR], 4.11-6.30) and endovascular treatment (OR, 3.79-8.33) of vasospasm were associated with an increased risk of all-cause readmission. Endovascular aneurysm treatment (OR, 0.22) was associated with a decreased risk of all-cause readmission. The average interval to the first follow-up appointment at our institution was 55.3 ± 63.3 days. Of the patients who had been readmitted from the emergency room, 65% had not had follow-up contact with physicians at our institution until their readmission. CONCLUSIONS: To the best of our knowledge, the present study is the first to have examined the readmission rates for subarachnoid hemorrhage >90 days after treatment. Our results have suggested that the readmission rates >90 days after treatment could still be predicted by the hospital and treatment course during admission and that follow-up appointments with patients earlier in the clinic could identify those patients with a greater risk of readmission.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Readmissão do Paciente / Hemorragia Subaracnóidea / Procedimentos Neurocirúrgicos / Procedimentos Endovasculares Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Readmissão do Paciente / Hemorragia Subaracnóidea / Procedimentos Neurocirúrgicos / Procedimentos Endovasculares Idioma: En Ano de publicação: 2020 Tipo de documento: Article